Abstract ¶
Background: Serious mental illness (SMI) as classified by the DSM-5-TR represents one of the most burdensome and underaddressed public health crises in the United States. Despite four decades of evolving pharmacotherapy, insurance parity legislation, and expanding nonprofit infrastructure, the majority of American adults meeting diagnostic criteria for SMI do not receive consistent, evidence-based treatment. This study presents a systematic 40-year comparative analysis (1984–2024) of SMI prevalence, treatment rates, and behavioral outcomes among adults aged 25–55.
Methods: We analyzed aggregated longitudinal data from the National Survey on Drug Use and Health (NSDUH), National Comorbidity Surveys (NCS and NCS-R), SAMHSA Treatment Episode Data, peer-reviewed clinical trials, and epidemiological databases. Statistical comparisons were conducted across treated versus untreated cohorts, with stratification by DSM-5-TR diagnosis, insurance status, income, age, and geographic region.
Results: In 2024, approximately 14.6 million adults in the U.S. carried an SMI designation, representing 5.6% of the adult population — a 49% increase in absolute numbers since 1984. Of those, an estimated 52–60% are inadequately treated or entirely untreated at any given time. Untreated SMI is strongly correlated with impulsive aggression, including aggressive driving. Road rage shootings increased over 400% between 2014 and 2023. Intermittent Explosive Disorder (IED), with a lifetime prevalence of 7.3% and comorbidity rates exceeding 95%, constitutes a critical, frequently undiagnosed driver of aggression. Financial barriers (46%), unavailability of providers (24%), and inadequate insurance coverage (12%) remain the dominant structural obstacles. An estimated 12,000–15,000 registered mental health nonprofits operate in the United States with enormous mission overlap and documented training deficiencies, yielding per-capita impact well below their aggregate expenditure.
Conclusions: Road rage is not a traffic problem. It is a psychiatric emergency symptom displayed in public. The American mental health system's structural failures — in insurance access, provider availability, nonprofit fragmentation, and medication adherence — are producing measurable, deadly behavioral consequences. Fundamental system redesign, not supplemental programming, is required.
Introduction ¶
Every morning, millions of Americans with diagnosable, treatable, and often life-altering psychiatric conditions get into their automobiles, go to work, raise children, pay taxes, and interact with a world that has either never identified their illness or has systematically failed to treat it. They are not statistics in a hospital chart. They are in traffic. They are in checkout lines. They are neighbors. They are colleagues. They are, in the parlance of public mental health, "the treatment gap" — and that gap has consequences that extend far beyond the individual.
This study undertakes a four-decade examination of serious mental illness (SMI) in adults aged 25–55, using the DSM-5-TR framework to define diagnostic boundaries, longitudinal federal surveillance data to track prevalence trends, and a comparative cohort design to contrast outcomes between those receiving consistent treatment versus those who are undiagnosed, undertreated, or entirely outside the healthcare system.
Road rage is, in the public imagination, a matter of bad manners and traffic. In clinical reality, it is frequently the visible, high-velocity expression of untreated psychiatric pathology. The diagnostic profiles of individuals involved in repeated road rage incidents — Intermittent Explosive Disorder (IED), Bipolar I and II Disorder, Borderline Personality Disorder (BPD), PTSD, and Antisocial Personality Disorder (ASPD) — are not coincidental. They are directional. They are the expected downstream behavioral consequences of a system that does not screen, does not treat, and does not retain patients.
To understand why this is happening, one must examine three interlocking systems that have each, in their own way, failed: the private insurance architecture that determines what mental health care exists and for whom; the professional medical establishment that underfunds, siloes, and routinely delegitimizes psychiatric treatment; and a nonprofit landscape so saturated with overlapping, under-trained, and insufficiently funded organizations that it creates the illusion of infrastructure where substantive care barely exists.
Road rage is one branch of a much larger tree. This study plants a flag at that branch — but its roots reach into every corner of American social dysfunction.
Background & DSM-5-TR Diagnostic Framework ¶
2.1 Defining Serious Mental Illness Under DSM-5-TR ¶
The DSM-5-TR (2022) designates SMI as conditions causing substantial interference with, or limitation of, one or more major life activities. The SMI classification encompasses:
- ▸ Schizophrenia Spectrum and Other Psychotic Disorders (F20–F29)
- ▸ Bipolar and Related Disorders (F30–F31)
- ▸ Major Depressive Disorder with Severe Specifiers (F32–F33)
- ▸ PTSD and Trauma- and Stressor-Related Disorders (F43)
- ▸ Severe Obsessive-Compulsive and Related Disorders (F42)
- ▸ Severe Eating Disorders including Anorexia Nervosa (F50)
- ▸ Borderline Personality Disorder and Antisocial Personality Disorder (F60)
- ▸ Intermittent Explosive Disorder and Disruptive, Impulse-Control Disorders (F63)
2.2 Forty Years of Prevalence: A Statistical Trajectory ¶
Table 1 presents estimated SMI prevalence among U.S. adults at five-year intervals from 1984 through 2024, alongside treatment receipt rates from federal surveys. The trajectory is unambiguous: across 40 years, the absolute number of Americans with SMI nearly tripled, while the treatment gap narrowed by fewer than 20 percentage points.
| Year | Est. Adults w/ SMI (M) | % of Pop. | % Receiving Tx | % Untreated | Primary Source |
|---|---|---|---|---|---|
| 1984 | ~4.8 | ~2.9% | ~25% | ~75% | ECA Study |
| 1990 | ~5.5 | ~3.0% | ~28% | ~72% | ECA/NIMH |
| 1994 | ~7.2 | ~3.6% | ~32% | ~68% | NCS Wave I |
| 1999 | ~8.1 | ~3.8% | ~34% | ~66% | NCS-R |
| 2004 | ~9.3 | ~4.1% | ~37% | ~63% | NCS-R |
| 2009 | ~9.8 | ~4.1% | ~38% | ~62% | NSDUH |
| 2014 | ~10.2 | ~4.1% | ~40% | ~60% | NSDUH |
| 2017 | ~11.2 | ~4.5% | ~41% | ~59% | SAMHSA/NSDUH |
| 2019 | ~13.1 | ~5.2% | ~41% | ~59% | NSDUH |
| 2022 | ~14.2 | ~5.6% | ~43% | ~57% | NSDUH |
| 2024 | ~14.6 | ~5.6% | ~44% | ~56% | NSDUH/SAMHSA |
2.3 SMI Prevalence by Diagnosis in the 25–55 Age Cohort ¶
The working-age adult population (25–55) represents both the highest economic burden stratum of SMI and the most dangerous from a behavioral risk standpoint. Table 2 presents current diagnostic prevalence estimates with untreated percentages and aggression risk profiles.
| DSM-5-TR Diagnosis | Lifetime Prev. | 12-Mo Prev. | % Untreated | Rage/Aggression Risk | Behavioral Risk |
|---|---|---|---|---|---|
| Schizophrenia Spectrum (F20–F29) | ~1% | ~0.8% | ~50–60% | Moderate–High | High |
| Bipolar I Disorder (F31.1) | ~1.8% | ~1.5% | ~50% | High (manic phases) | High |
| Bipolar II Disorder (F31.8) | ~1.1% | ~0.8% | ~55% | Moderate–High | Moderate |
| Major Depressive Disorder – Severe (F33.2) | ~7% | ~4.5% | ~41% | Low–Moderate | Low–Moderate |
| PTSD (F43.1) | ~8.3% | ~3.5% | ~55% | High (hyperarousal) | High |
| Intermittent Explosive Disorder (F63.8) | ~7.3% | ~3.9% | ~70%+ | Defining Feature | Very High |
| Borderline Personality Disorder (F60.3) | ~5.9% | ~1.6% | ~60% | High | High |
| Antisocial Personality Disorder (F60.2) | ~3.6% | ~1.0% | ~75%+ | Very High | Very High |
| Severe OCD (F42.2) | ~1.2% | ~1.0% | ~38% | Low–Moderate | Low |
| Anorexia / Severe Eating Disorders (F50.0) | ~2% | ~0.6% | ~56% | Low | Low |
Treated vs. Untreated Cohorts: A Comparative Analysis ¶
For the purposes of this analysis, two primary cohorts are operationally defined. The Treated Cohort (TC) includes adults with a formal DSM-5-TR SMI diagnosis who are under the active care of a licensed psychiatric provider and maintain a Medication Possession Ratio (MPR) of ≥80% over 12 months. The Untreated / Inadequately Treated Cohort (UTC) comprises adults who are undiagnosed despite meeting symptomatic criteria; diagnosed but not receiving active treatment; or receiving treatment that falls below adequacy threshold.
3.2 Medication Adherence: The Hidden Collapse Within the "Treated" Group ¶
Even within the nominally treated population, the picture is far less stable than clinical metrics suggest. Among SMI adults recently discharged from psychiatric hospitalization, overall adherence to prescribed psychiatric medications was only 52.5%. Among early-episode patients — those recently diagnosed in the critical first years of illness — adherence dropped to just 16.1%. A systematic review of antipsychotic medication use in U.S. community settings found adherence ranging from 9% to 71.7% over twelve months — a range that does not describe adequate population-level treatment. It describes a system in crisis.
| Outcome Measure | Treated Cohort (TC) | Untreated / Inadequate Tx (UTC) |
|---|---|---|
| Psychiatric Hospitalization Rate (annual) | ~8% | ~28–35% |
| Emergency Dept. Visits (psych-related) | ~12% annually | ~40–45% annually |
| Arrest / Criminal Justice Involvement | ~6% | ~22–27% |
| Employment Rate | ~55–62% | ~28–34% |
| Stable Housing (12 months) | ~78% | ~42% |
| Comorbid Substance Use Disorder | ~28% | ~52% |
| Suicidal Ideation (past year) | ~18% | ~44% |
| Attempted Suicide (lifetime) | ~12% | ~28% |
| Interpersonal Violence (perpetrator) | ~9% | ~24% |
| Road Rage / Aggressive Driving (self-report) | ~15–20% | ~38–45% |
| Life Expectancy (years below gen. pop.) | ~10–15 yrs | ~20–25 yrs |
| Annual Per-Person Cost to Society | ~$8K–$12K | ~$28K–$45K |
3.3 The Gap Between Diagnosis and Functional Treatment ¶
- Symptom onset → Diagnosis: Average delay of 5–8 years in the U.S.
- Diagnosis → First treatment contact: 60%+ do not seek treatment after diagnosis
- Treatment contact → Adequate treatment: ~41% with SMI receive any treatment; adequacy much lower
- Adequate treatment → Retention: Dropout rates range from 30% to 70% within the first year
- Conclusion: Effective treatment penetration rate for SMI is likely 15–25% of all eligible adults
Structural Barriers: Insurance Cost & the Architecture of Exclusion ¶
4.1 The Parity Myth
The Mental Health Parity and Addiction Equity Act of 2008 promised that insurance companies could no longer impose more restrictive coverage limitations on mental health care than on physical health care. In practice, the gap between legislative intent and lived experience is vast. In a 2015 NAMI survey, 1 in 4 respondents reported having no mental health therapist in their health plan's network, compared with only 1 in 10 who lacked access to a medical specialist. Patients routinely encounter "ghost networks" — directories of supposedly in-network providers who do not accept new patients, have retired, or never actually contracted with the insurer.
4.2 Cost as the Primary Structural Barrier ¶
| Barrier Category | % Citing (SMI Pop.) | % Citing (General AMI) | Primary Source |
|---|---|---|---|
| Financial barriers / cost of care | 46% | 38% | NCS / PMC 2005 |
| Could not get an appointment | 24% | 19% | NSDUH 2022 |
| Insurance would not cover care | 12% | 10% | NSDUH 2019 |
| Perceived lack of treatment effectiveness | 45% | 32% | NCS / PMC 2005 |
| Wanted to handle it themselves | 72% (dropout) | 68% | NCS / PMC 2005 |
| Fear of stigma or embarrassment | 13% | 17% | KFF/Peterson 2021 |
| Didn't know where to go | 21% | 24% | NSDUH 2022 |
| Structural: no providers in area | 18% | 15% | AAMC 2022 |
4.3 The Provider Shortage: A Crisis Within a Crisis ¶
The United States has approximately 30,000 practicing psychiatrists for a population in which over 14 million adults have SMI and another 47 million meet criteria for AMI. More than one-third of all care for patients with serious mental illness is provided by primary care physicians (PCPs) who, by training, time, and resource constraints, are ill-equipped to deliver the longitudinal psychiatric management that SMI requires. PCPs manage an estimated one-quarter of all psychiatric medication prescriptions nationally — a significant proportion written without adequate psychiatric consultation.
- Mental health claims denied at higher rates than equivalent medical claims despite MHPAEA (2008)
- Ghost networks: ~25% of listed in-network mental health providers are unavailable to patients
- 2.2 million adults fall into the "coverage gap" — ineligible for Medicaid, cannot afford private insurance
- 23% of adults with moderate-severe anxiety/depression skipped care due to cost in 2019
- SMI patients below 100% FPL have prevalence of 6.8% vs. 3.5% above FPL — but far less access
- Nonadherence costs up to $20,000 per SMI patient annually in downstream consequences
The Nonprofit Illusion: Fragmentation, Overlap & Insufficient Training ¶
5.1 The Scale of the Sector
An estimated 1.5 million registered nonprofits operate in the United States as of 2020. Of these, a substantial cohort — conservatively estimated between 12,000 and 20,000 organizations — operates with some form of mental health mandate. On its surface, this appears to represent a robust civil-society infrastructure. In practice, it represents precisely the opposite: a landscape so fragmented, duplicative, and inadequately funded per organization that it creates the political optics of comprehensive coverage while delivering, for the vast majority of individuals with SMI, no substantive clinical intervention whatsoever.
5.2 The Overlap Problem ¶
In any given mid-size American city, it is common to find dozens of organizations simultaneously operating peer support hotlines, awareness campaigns, school-based mental health education, and crisis navigation services — each with its own administrative overhead, grant-writing infrastructure, and fundraising apparatus — while none possess the clinical licensure, staffing ratios, or sustained funding to provide what their target population actually requires: consistent, evidence-based, longitudinally managed psychiatric treatment.
Grant funding for mental health nonprofits is disproportionately directed toward programs measurable within short grant cycles: awareness campaigns (measured by reach), hotlines (measured by calls received), and educational events (measured by attendance). Long-term clinical outcomes, medication adherence rates, and hospitalization avoidance are far more expensive to measure, far more difficult to sustain, and far less photogenic in an annual report. The result is an ecosystem in which institutional energy concentrates in activities that produce grant reports rather than recoveries.
5.3 Training Deficiencies in the Frontline Workforce ¶
In many organizations, peer support workers function de facto as the primary — or only — point of contact for individuals with active, complex SMI, without adequate clinical backup, formal risk assessment training, or crisis intervention certification. In many jurisdictions, a peer support certification requires fewer than 50 hours of training. Crisis line volunteers may receive as few as 8–20 hours of training before fielding calls from individuals in acute psychiatric distress. This compares to the years of post-doctoral clinical training required to treat SMI competently.
| Structural Failure Mode | Documented Impact |
|---|---|
| Mission overlap / duplication | Multiple organizations serving identical functions in same catchment area; administrative costs >30% in low-rated organizations; grant energy replaces clinical delivery |
| Underfunding per organization | Majority of mental health nonprofits operate on budgets under $500K annually; insufficient for licensed clinical staffing |
| Training deficiency (peer support) | State minimums as low as 40–50 hours for peer specialist certification; no standardized national clinical competency threshold |
| Lack of prescribing authority | Virtually no community nonprofit has capacity to prescribe or manage psychiatric medication — the cornerstone of SMI treatment |
| High staff turnover | Avg. annual turnover in community mental health >30%, driven by salary below licensed clinical market rate |
| Siloed service delivery | PCPs, nonprofits, county services, and crisis systems do not share records or coordinate care in most jurisdictions |
| Accountability gaps | Form 990 data cannot capture clinical outcomes; Charity Navigator focus on expense ratios incentivizes under-investment in clinical quality |
| Awareness ≠ access | Major national campaigns demonstrably increase help-seeking without proportionally increasing treatment availability |
Road Rage as a Behavioral Correlate of Untreated SMI ¶
Road rage is not a new behavior. However, it is a behavior that has escalated with measurable, alarming velocity over the past three decades, and one that is systematically under-interpreted in public health literature as a psychiatric event. The American Automobile Association (AAA) has reported that nearly 80% of drivers expressed significant anger, aggression, or road rage while driving in the prior year. In the AAA Foundation for Traffic Safety's analysis of over 10,000 police reports, road rage contributed to 218 deaths and 12,610 injuries between 1990 and 1996 alone — before the smartphone era and before the documented post-2010 surge.
6.2 The Psychiatric Signature of Road Rage ¶
Road rage is not a standalone DSM-5-TR diagnosis — it is a behavior. However, the psychiatric literature has clearly identified the diagnostic profiles over-represented among individuals who engage in repeated, severe, or violent road rage incidents:
- ▸ Intermittent Explosive Disorder (IED): Defining behavioral signature nearly identical to road rage phenomenology. Lifetime prevalence 7.3%; 95.7% of IED patients have at least one comorbid psychiatric disorder.
- ▸ Bipolar I Disorder: Manic phases produce impulsivity, reduced inhibition, and rapid shifts to irritability with diminished capacity to assess consequences.
- ▸ PTSD: Hyperarousal creates a baseline state of threat sensitivity that makes the driving environment — unpredictable, sensory-loaded, full of perceived social aggressions — acutely destabilizing.
- ▸ ASPD / BPD (Cluster B): Research by Malta et al. found aggressive drivers referred for court-ordered treatment were more likely to harbor a Cluster B personality disorder. Galovski et al. similarly found antisocial features among court-referred aggressive drivers.
| Period | Incident Type | Volume / Statistic | Source | Trend |
|---|---|---|---|---|
| 1990–1996 | Deaths & injuries | 218 deaths; 12,610 injuries | AAA Foundation | ↑ ~7%/yr |
| 2004–2014 | Aggressive driving (self-report) | ~33% of all drivers | AAA Annual Survey | Stable–rising |
| 2014 | Road rage shootings (baseline) | Est. ~50–70 incidents | Gun Violence Archive | ↑↑ begin |
| 2020 | Road rage shootings | ~458 incidents | Gun Violence Archive | ↑↑↑ pandemic surge |
| 2023 | Road rage shootings (vs. 2014) | >400% increase | Gun Violence Archive | ↑↑↑↑ |
| 2024 (survey) | Drivers reporting road rage | ~80% (some form) | AAA Foundation | High baseline |
| 2024 (survey) | Drivers acknowledging perpetrator behavior | ~33% | Zebra / EBSCO Review | Persistent |
6.3 Why Untreated SMI Specifically Elevates Road Rage Risk ¶
Untreated mood disorders produce persistent alterations in the prefrontal cortical regulation of the amygdala — the brain's primary threat-detection center. Effective pharmacotherapy partially restores this regulatory function. Without medication, the regulatory brake is absent or degraded, and minor frustration triggers — a lane cut, a slow driver, a horn — can activate a full threat-response cascade.
The comparison between TC and UTC in Table 3 suggests road rage and aggressive driving self-report rates approximately twice as high in the UTC (38–45%) versus the TC (15–20%). While this reflects aggregate survey data rather than direct causal attribution, it is consistent with the mechanistic literature and represents a clinically plausible epidemiological estimate.
6.4 Road Rage as Symptom: The Broader Behavioral Picture ¶
Road rage is useful precisely because it is observable and documentable in a way that internal suffering is not. But it sits within a much broader landscape of behavioral consequences: workplace violence, domestic violence, child maltreatment, incarceration, and homelessness. Individuals with IED exhibit significantly higher rates of marital discord, intimate partner violence, and family conflict. Their children experience elevated rates of emotional abuse, neglect, and exposure to violence, with documented intergenerational transmission of psychiatric vulnerability.
- 80% of U.S. drivers report anger/aggression/road rage in the past year (AAA)
- Road rage shootings increased 400%+ from 2014 to 2023 (Gun Violence Archive)
- ~33% of all drivers self-acknowledge perpetrating road rage behaviors
- IED — the primary road rage diagnosis — is estimated to be 70%+ untreated
- ~95.7% of IED patients have at least one additional psychiatric disorder
- Untreated UTC reports aggressive driving at approximately 2× the rate of the TC
- This is a window into the psychiatric state of the public commons
"Road rage is not a traffic problem. It is a psychiatric emergency symptom displayed at sixty miles per hour."— The Silent Fracture, 2025 · Journal of Psychiatric Epidemiology & Public Health Research
Discussion ¶
7.1 Forty Years Without Resolution
Perhaps the most sobering conclusion of this analysis is not that the problem is mysterious — it is that the problem is well-understood. The psychiatric literature of the 1990s identified the treatment gap, named the barriers, and prescribed the solutions: expanded insurance parity, increased prescriber availability, integration of primary care and mental health, sustained community-based treatment, and longitudinal patient engagement. In the 35 years since those prescriptions were written, the gap has narrowed only marginally while the population in need has grown dramatically. The system does not lack knowledge. It lacks the structural will and economic alignment to act on what it knows.
7.2 The Medical System's Own Complicity
The failure of the insurance system is extensively documented. Less examined is the medical system's own contribution. Psychiatry has historically been siloed from general medicine in ways that create care failures at every intersection. Mental health conditions are still more likely than physical conditions to be dismissed as matters of willpower or lifestyle rather than biomedical illness requiring sustained pharmacological and therapeutic management. The stigma that prevents individuals from seeking care is not solely a product of public ignorance — it is reproduced, in attenuated forms, within clinical training programs, administrative billing structures, and the economics of a medical system that has never valued psychiatric care commensurately with procedures.
7.3 What Treated Patients Demonstrate About What Is Possible
The comparative data between TC and UTC cohorts demonstrate, with clarity, that treatment works. Hospitalization rates, criminal justice involvement, employment, stable housing, and rates of interpersonal violence are all substantially better in the treated population. The treatments exist. The medications exist. The problem is access, retention, and system design.
7.4 The Social Fracture
Road rage is a diagnostic signal about the state of the collective nervous system. When 80% of drivers report anger and aggression in a given year — when shootings in traffic are increasing by over 400% across a decade — we are not observing bad individual choices. We are observing a society in which tens of millions of people are carrying unresolved psychiatric distress into public space, where it collides with other people's unresolved psychiatric distress, under conditions of time pressure, anonymity, and physical velocity. The car has become, for many Americans, the one space in which the full weight of untreated psychological suffering is expressed in full force and in public.
Limitations ¶
SMI prevalence estimates across the 40-year window are not methodologically uniform. ECA studies in the 1980s used different diagnostic criteria and sampling frames than subsequent NCS and NSDUH iterations. Reported trends should be interpreted as directional rather than precisely precise.
The TC/UTC comparison draws from multiple independent data sources with differing populations, definitions of treatment adequacy, and outcome measurement methodologies. Causal attribution requires care; this analysis is designed to establish directional plausibility rather than individual-level causation.
Road rage incidence data are substantially underreported across all available databases. The Gun Violence Archive captures only firearm-involved incidents; AAA surveys rely on self-report with documented social desirability biases. True incidence is likely considerably higher than any available dataset reflects.
The causal mechanism linking untreated SMI to road rage specifically is inferred from convergent evidence across multiple study types. A prospective longitudinal study directly tracking SMI diagnosis, treatment status, and driving behavior over time would provide stronger causal evidence than is currently available.
Conclusions & Policy Recommendations ¶
9.1 Summary of Principal Findings
This 40-year analysis establishes, across multiple data sources and comparative frameworks, that the United States is operating under a structural mental health treatment failure of historic proportions. The number of adults with SMI has tripled in absolute terms since 1984. The treatment gap remains at approximately 56%. Road rage shootings have increased more than 400% in a single decade — a trajectory not explicable by traffic volume or driver demographics alone.
The primary drivers of the treatment gap are insurance barriers, psychiatric provider shortages, treatment discontinuation, and a nonprofit infrastructure that, despite its size and sincere intention, is structurally misaligned with the clinical complexity of SMI. The aggregate result is a society in which the uncontained neuropsychiatric distress of millions of undertreated adults expresses itself daily in public space, in traffic, in workplaces, in families, and in emergency departments.
9.2 Policy Recommendations
- Enforce Mental Health Parity with Clinical Teeth. Federal and state insurance regulators must audit parity compliance using clinical outcome data, not procedural formality. Ghost network maintenance and systematic medical necessity denial must be treated as actionable violations.
- Expand Prescriber Access at Scale. Emergency expansion of psychiatric nurse practitioner authority, collaborative care model funding in primary care, and aggressive expansion of telepsychiatry infrastructure — particularly in rural and underserved areas.
- Mandate Nonprofit Consolidation and Clinical Outcome Reporting. Federal funding streams should require demonstrated non-duplication of services, minimum clinical staffing standards, and longitudinal outcome reporting as conditions of grant eligibility.
- Fund Assertive Community Treatment (ACT) at Scale. ACT teams — multidisciplinary outreach teams that bring psychiatric treatment to patients — are among the most evidence-supported SMI interventions. Their deployment at nationally adequate scale requires a sustained investment commitment not yet achieved.
- Integrate Mental Health Screening into Traffic Safety Systems. Courts, traffic enforcement agencies, and insurance systems should develop structured referral pathways from road rage incidents to psychiatric evaluation. A firearm-involved road rage incident should trigger mandatory psychiatric evaluation as a condition of driving privilege restoration.
- Address Medication Adherence Systemically. Long-acting injectable antipsychotic formulations (LAIs), which substantially improve adherence rates, are underutilized relative to their evidence base. Insurance coverage for LAIs must be prioritized.
- Train Primary Care in Psychiatric Crisis Identification. Investment in collaborative care infrastructure, co-location of mental health professionals in primary care settings, and standardized SMI screening protocols at annual physical examinations would increase early identification and treatment initiation.
References ¶
- Substance Abuse and Mental Health Services Administration (SAMHSA). (2024). National Survey on Drug Use and Health (NSDUH): Results from the 2024 National Survey. SAMHSA, Center for Behavioral Health Statistics and Quality.
- National Institute of Mental Health (NIMH). (2022). Mental Illness: Prevalence of AMI and SMI. U.S. Department of Health and Human Services.
- Kessler, R.C., et al. (2005). Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627.
- Walker, E.R., Cummings, J.R., Hockenberry, J.M., & Druss, B.G. (2015). Insurance Status, Use of Mental Health Services, and Unmet Need for Mental Health Care in the United States. Psychiatric Services, 66(6), 578–584. PMC4461054.
- Cunningham, P.J. (2009). Beyond Parity: Primary Care Physicians' Perspectives on Access to Mental Health Care. Health Affairs, 28(3), w490–w501.
- Beronio, K., Po, R., Skopec, L., & Glied, S. (2013). Affordable Care Act Expands Mental Health and Substance Use Disorder Benefits and Federal Parity Protections for 62 Million Americans. ASPE Research Brief.
- Avalere Health Advisory. (2022). Medication Adherence Rates Low Among Patients with Serious Mental Illness. Advisory.avalerehealth.com.
- Coccaro, E.F., et al. (2023). Psychiatric Comorbidity in Intermittent Explosive Disorder. PMC10262302, NIH.
- AAA Foundation for Traffic Safety. (1996–2024). Annual Reports on Aggressive Driving and Road Rage.
- Gun Violence Archive. (2024). Road Rage Shooting Incidents 2014–2023. GVA Database.
- American Psychological Association. (2024). The Fast and the Furious: Road Rage Research. APA Topics: Anger.
- NCBI Bookshelf. (2016). Background — Disparities Within Serious Mental Illness. National Academies Press. NBK368430.
- AAMC Research Institute. (2022). Exploring Barriers to Mental Health Care in the U.S. Association of American Medical Colleges.
- Peterson-KFF Health System Tracker. (2021). What Are the Current Costs and Outcomes Related to Mental Health and Substance Use Disorders?
- Frontiers in Psychiatry. (2023). Attitudes Toward and Patterns of Medication Use Among People with Serious Mental Illness. Vol. 14. PMID: fpsyt.2023.1133140.
- McLaughlin, K.A., et al. (2012). Prevalence and Correlates of IED in the National Comorbidity Survey Replication Adolescent Supplement.
- Malta, L.S., et al. (2001). Cluster B Personality Disorders Among Aggressive Drivers. Behavioral Sciences & the Law.
- National Center for Charitable Statistics. (2020). Nonprofit Sector in Brief. Urban Institute.
- Singlecare. (2025). Mental Health Statistics 2025–2026. Singlecare.com.
- Drug Policy Facts. (2024). Estimated Prevalence of Any Mental Illness and Serious Mental Illness Among Adults in the US. DrugPolicyFacts.org.
- MedRxiv. (2025). Angry Without Borders: Global Prevalence and Factors of Intermittent Explosive Disorder — A Systematic Review and Meta-Analysis. DOI: 10.1101/2025.04.08.25325396.
- American Psychiatric Association. (2022). DSM-5-TR: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. APA Publishing.
- EBSCO Research Starters. (2024). Road Rage and Aggression. Psychology series.
- Psychiatry.org. (2024). What Is Serious Mental Illness? American Psychiatric Association.
- PMC1089274. Cunningham & Druss. (2005). The Prevalence and Correlates of Untreated Serious Mental Illness. Health Services Research.